To Assess Continued Safety of and Adherence to the Dapivirine (25 mg) Vaginal Ring-004 in Healthy, HIV-negative Women

NCT02862171 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
941
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

International Partnership for Microbicides, Inc.